MPL W515 and JAK2 V617 mutation analysis in patients with refractory anemia with ringed sideroblasts and an elevated platelet count.

David P. Steensma, Jonathan S C Caudill, Animesh D Pardanani, Rebecca F. McClure, Terra L. Lasho, Ayalew Tefferi

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Discovery of a constitutively activating point mutation of the Janus kinase 2 (JAK2) receptor-associated tyrosine kinase in patients with polycythemia vera (PV) and other BCR/ABL-negative myeloproliferative disorders prompted many groups around the world to examine diverse subsets of patients with myeloid diseases for the prevalence of the JAK2 V617F mutation and its clinical and pathological associations.

Original languageEnglish (US)
JournalHaematologica
Volume91
Issue number12 Suppl
StatePublished - Dec 2006

Fingerprint

Janus Kinase 2
Refractory Anemia
Platelet Count
Myeloproliferative Disorders
Polycythemia Vera
Mutation
Receptor Protein-Tyrosine Kinases
Point Mutation

ASJC Scopus subject areas

  • Hematology

Cite this

MPL W515 and JAK2 V617 mutation analysis in patients with refractory anemia with ringed sideroblasts and an elevated platelet count. / Steensma, David P.; Caudill, Jonathan S C; Pardanani, Animesh D; McClure, Rebecca F.; Lasho, Terra L.; Tefferi, Ayalew.

In: Haematologica, Vol. 91, No. 12 Suppl, 12.2006.

Research output: Contribution to journalArticle

@article{e7f095b5176442209ec015f66d2070be,
title = "MPL W515 and JAK2 V617 mutation analysis in patients with refractory anemia with ringed sideroblasts and an elevated platelet count.",
abstract = "Discovery of a constitutively activating point mutation of the Janus kinase 2 (JAK2) receptor-associated tyrosine kinase in patients with polycythemia vera (PV) and other BCR/ABL-negative myeloproliferative disorders prompted many groups around the world to examine diverse subsets of patients with myeloid diseases for the prevalence of the JAK2 V617F mutation and its clinical and pathological associations.",
author = "Steensma, {David P.} and Caudill, {Jonathan S C} and Pardanani, {Animesh D} and McClure, {Rebecca F.} and Lasho, {Terra L.} and Ayalew Tefferi",
year = "2006",
month = "12",
language = "English (US)",
volume = "91",
journal = "Haematologica",
issn = "0390-6078",
publisher = "Ferrata Storti Foundation",
number = "12 Suppl",

}

TY - JOUR

T1 - MPL W515 and JAK2 V617 mutation analysis in patients with refractory anemia with ringed sideroblasts and an elevated platelet count.

AU - Steensma, David P.

AU - Caudill, Jonathan S C

AU - Pardanani, Animesh D

AU - McClure, Rebecca F.

AU - Lasho, Terra L.

AU - Tefferi, Ayalew

PY - 2006/12

Y1 - 2006/12

N2 - Discovery of a constitutively activating point mutation of the Janus kinase 2 (JAK2) receptor-associated tyrosine kinase in patients with polycythemia vera (PV) and other BCR/ABL-negative myeloproliferative disorders prompted many groups around the world to examine diverse subsets of patients with myeloid diseases for the prevalence of the JAK2 V617F mutation and its clinical and pathological associations.

AB - Discovery of a constitutively activating point mutation of the Janus kinase 2 (JAK2) receptor-associated tyrosine kinase in patients with polycythemia vera (PV) and other BCR/ABL-negative myeloproliferative disorders prompted many groups around the world to examine diverse subsets of patients with myeloid diseases for the prevalence of the JAK2 V617F mutation and its clinical and pathological associations.

UR - http://www.scopus.com/inward/record.url?scp=37749011577&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=37749011577&partnerID=8YFLogxK

M3 - Article

VL - 91

JO - Haematologica

JF - Haematologica

SN - 0390-6078

IS - 12 Suppl

ER -